An exploratory routine-laboratory renal dysfunction-coagulopathy phenotype identifies high-risk ICU patients with pneumonia: MIMIC- IV derivation and fixed-centroid Chinese external validation

When a patient arrives at an intensive care unit with pneumonia, they are not all the same. While the diagnosis is the same, the way their bodies are failing can be wildly different. One person might have a struggling heart but healthy kidneys, while another might have blood that clumps too easily and organs that are shutting down. Doctors have long used scoring systems to measure how sick a patient is, but these scores often act like a single number summarizing a complex story. They tell you how severe the situation is, but they do not always explain why the patient is sick or which specific type of illness they are fighting. This lack of clarity makes it hard to predict who will survive or who might need specific, life-saving support like a machine to filter their blood.

Researchers have begun to look for a better way to sort these patients. Instead of just measuring how bad things are, they are trying to find distinct groups, or "phenotypes," of patients who share similar patterns in their blood work. The goal is to see if simple, routine blood tests taken early in a hospital stay can reveal these hidden groups. If doctors can identify a specific type of pneumonia patient who is likely to have kidney failure and blood clotting problems, they might be able to spot them immediately and watch them more closely. This approach moves beyond guessing and toward understanding the specific biological state of the patient.

A team of researchers set out to test this idea using data from two very different places. First, they looked at a massive database of medical records from a hospital in the United States, known as MIMIC-IV. This database contains information from thousands of adult patients who were admitted to the intensive care unit with pneumonia. The researchers focused on the first day these patients were in the hospital, extracting eleven routine blood measurements that are available in almost every hospital. These tests checked the number of blood cells, how well the blood clots, how the kidneys are working, and the balance of salts in the body. They did not use complex, expensive, or rare tests that might not be available everywhere. They simply used the standard numbers that a doctor sees on a screen every morning.

Using a computer method that groups similar things together, the researchers analyzed these blood patterns to see if they naturally formed distinct clusters. They found that the patients did not just fall into a single line from "not sick" to "very sick." Instead, the data sorted them into three clear groups. The first group had blood work that looked relatively normal, with healthy kidney function and blood clotting. The second group showed signs of trouble, such as lower blood cell counts and some shifts in the balance of salts in the body. The third group was the most alarming. These patients had clear signs of kidney dysfunction, meaning their bodies were not filtering waste properly, combined with abnormal blood clotting and a significant imbalance of salts.

The results showed that these groups were not just random collections of numbers; they predicted very different outcomes. In the large American dataset, the patients in the first, healthiest group had a death rate of about 17 percent. The middle group had a death rate of about 23 percent. But the third group, the one with the kidney and clotting problems, had a death rate of over 32 percent. More importantly, the need for continuous renal replacement therapy—a machine that acts as an artificial kidney to filter the blood—varied drastically between the groups. Only about 2 percent of the first group needed this machine, while nearly 23 percent of the third group required it. This suggested that the blood tests were successfully identifying a specific, high-risk type of patient who was likely to need intense organ support.

To see if this finding was real and not just a fluke of one hospital's data, the researchers tested it on a completely different group of patients. They took the exact rules and patterns they had found in the American data and applied them to a smaller group of 412 patients with severe pneumonia admitted to a hospital in Shanghai, China. They did not re-analyze the Chinese data to find new groups; instead, they simply asked the computer to place each Chinese patient into the three groups defined by the American data. This is like using a map drawn in one country to navigate a city in another.

The results in China followed the same pattern. The patients who fell into the third group—the one with kidney and clotting issues—had the highest death rate, at 50 percent, and the highest need for kidney support machines, at nearly 64 percent. The patients in the first group had the lowest death rate. While the numbers were different because the Chinese group was specifically selected for having severe pneumonia, the direction of the risk was exactly the same. The group identified as high-risk in the United States was also the high-risk group in China. This consistency suggests that the pattern of kidney failure and blood clotting problems is a universal sign of extreme danger in pneumonia patients, recognizable across different healthcare systems and populations.

The researchers also checked to make sure their findings were stable. They ran their analysis many times with different starting points to ensure the computer was not just finding a random pattern. In almost every attempt, the same three groups emerged, and the high-risk group consistently remained the one with the worst outcomes. They also checked if the results held up when they looked at the data in smaller chunks, and the high-risk group remained the most dangerous in nearly all cases. This gave them confidence that the pattern was robust and not a mistake in the calculation.

However, the study does not claim to have solved the problem of treating pneumonia. The researchers were careful to state that identifying these groups does not automatically tell a doctor how to treat a patient. It does not prove that giving a specific drug to the high-risk group will save them. The study is an observation, a way of seeing the landscape more clearly. It suggests that routine blood tests can reveal a specific, dangerous state of illness that goes beyond a general severity score. The fact that this pattern appears in both the United States and China, using only standard tests, means it could be a useful tool for doctors everywhere to identify patients who need extra attention.

The work highlights that pneumonia is not a single disease but a collection of different physiological states. Some patients are fighting a battle that primarily affects their lungs, while others are fighting a systemic battle that attacks their kidneys and blood. By using simple, everyday lab tests, doctors might soon be able to spot the patients who are fighting the latter battle much earlier. This could lead to better monitoring and perhaps, in the future, better treatments tailored to these specific types of patients. For now, the study stands as a proof that these hidden groups exist and can be found without expensive equipment, offering a clearer view of the critical moments when a patient with pneumonia is in the most danger.